Seroatlas · Human Serome Atlas

TNFSF13B

Tumor necrosis factor ligand superfamily member 13B

Also known as: BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TN13B_HUMAN, TNFSF20

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9Y275
Gene
TNFSF13B
Ensembl
ENSG00000102524
Chromosome
13
Canonical length
285 aa
Protein class
Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins
Subcellular location
Vesicles,Plasma membrane,Focal adhesion sites
Secretome location
Secreted to blood
Quaternary structure
Homotrimer

OverviewNCBI Gene

The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This cytokine is a ligand for receptors TNFRSF13B/TACI, TNFRSF17/BCMA, and TNFRSF13C/BAFFR. This cytokine is expressed in B cell lineage cells, and acts as a potent B cell activator. It has been also shown to play an important role in the proliferation and differentiation of B cells. Alternatively spliced transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Mar 2011]

Canonical amino-acid sequenceUniProt

285 residues, UniProt reviewed canonical sequence.

>Q9Y275|TNFSF13B
     1  MDDSTEREQS RLTSCLKKRE EMKLKECVSI LPRKESPSVR SSKDGKLLAA TLLLALLSCC
    61  LTVVSFYQVA ALQGDLASLR AELQGHHAEK LPAGAGAPKA GLEEAPAVTA GLKIFEPPAP
   121  GEGNSSQNSR NKRAVQGPEE TVTQDCLQLI ADSETPTIQK GSYTFVPWLL SFKRGSALEE
   181  KENKILVKET GYFFIYGQVL YTDKTYAMGH LIQRKKVHVF GDELSLVTLF RCIQNMPETL
   241  PNNSCYSAGI AKLEEGDELQ LAIPRENAQI SLDGDVTFFG ALKLL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against TNFSF13B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.47
Highest tissue expression
24 nTPM

Expression across tissuesHPA

Tissue

  • appendix: 24 nTPM
  • lymph node: 20 nTPM
  • bone marrow: 19 nTPM
  • tonsil: 17 nTPM
  • spleen: 15 nTPM
  • gallbladder: 12 nTPM

Single-cell type

  • neutrophils: 420 nCPM
  • monocytes: 258 nCPM
  • cdc: 219 nCPM
  • monocyte progenitors: 202 nCPM
  • kupffer cells: 189 nCPM
  • choroid plexus epithelial cells: 144 nCPM

Immune cell

  • neutrophil: 509 nTPM
  • classical monocyte: 352 nTPM
  • intermediate monocyte: 273 nTPM
  • non-classical monocyte: 236 nTPM
  • myeloid DC: 207 nTPM
  • total PBMC: 166 nTPM

Brain region

  • medulla oblongata: 11 nTPM
  • choroid plexus: 9.7 nTPM
  • white matter: 8.5 nTPM
  • spinal cord: 7.6 nTPM
  • pons: 6.6 nTPM
  • cerebral cortex: 5.7 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.24
gnomAD pLI
0.98
gnomAD missense Z
2.14
DepMap mean gene effect
-0.04
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of TNFSF13B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads TNFSF13B as an antibody target. Whether an autoantibody or antibody against TNFSF13B could matter depends on whether native TNFSF13B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

TNFSF13B is annotated at the cell surface, where native TNFSF13B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label TNFSF13B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/TNFSF13B. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...